NASDAQ
Kymera Therapeutics, Inc. (KYMR) has a fcf yield of -3.57% as of Friday, May 29, 2026. This represents a 55.36% increase compared to its 12-month average of -7.99%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.